Hospital, oncology, and pulmonology leaders will benefit from following the research that builds on this innovative study and the treatments that may emerge.
New research shows the promise of repurposing existing drugs for new precision medicine treatments.
From personalized 3D printed medications to gene-adjusted radiation dosing, here are five advances that significantly improved hospitals’ ability to provide personalized care and improve patient outcomes.
Researchers questioned what distinguishes mutations in terms of clinical relevance, the goal to identify genes responsible for the spread of cancer cells.
Innovative hospital leaders following precision medicine developments will benefit from understanding how precision medicine is developing beyond genetics.
Geisinger researchers will develop a tool that shortens the time for diagnosing common diseases that have a genetic cause, allowing hospitals to respond more quickly to these conditions.
Billionaire funds particle accelerator technology that saved his life, enabling Michigan State University to provide precision medicine radiopharmaceutical treatments.
University of Michigan Health System researchers and others are working for a fundamental change in kidney disease health economics and outcomes.
In good news for hospitals that use information from the Clinical Genome Resource Consortium, federal grants allow the consortium’s contributors to keep curating important precision medicine research.
A key insight of this study is how comprehensive genomic sequencing (CGS) provided a detailed perspective of the genetic makeup of each patient’s tumor.